| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.845 | 38.893 | 39.607 | 27.238 | 29.679 | 47.275 | 47.111 | 62.516 | 47.913 | 47.504 |
| Total Income - EUR | 28.846 | 39.094 | 40.092 | 27.294 | 29.683 | 47.521 | 47.121 | 62.642 | 47.955 | 47.504 |
| Total Expenses - EUR | 35.197 | 32.194 | 33.151 | 28.880 | 28.375 | 39.143 | 43.876 | 56.323 | 49.609 | 48.430 |
| Gross Profit/Loss - EUR | -6.351 | 6.900 | 6.941 | -1.586 | 1.307 | 8.377 | 3.246 | 6.319 | -1.654 | -925 |
| Net Profit/Loss - EUR | -7.216 | 5.733 | 5.752 | -2.404 | 417 | 7.068 | 1.832 | 4.443 | -1.654 | -925 |
| Employees | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Semliv Genetic International Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.480 | 0 | 0 | 6.646 | 4.560 | 2.552 | 1.206 | 371 | 0 | 0 |
| Current Assets | 10.290 | 16.784 | 26.136 | 8.768 | 9.523 | 25.818 | 29.534 | 15.325 | 13.441 | 15.965 |
| Inventories | 2 | 2 | 29 | 82 | 80 | 79 | 258 | 259 | 302 | 300 |
| Receivables | 8.212 | 12.446 | 15.231 | 4.846 | 1.714 | 5.642 | 14.413 | 8.079 | 10.676 | 7.979 |
| Cash | 2.075 | 4.336 | 10.876 | 3.839 | 7.729 | 20.098 | 14.863 | 6.986 | 2.463 | 7.686 |
| Shareholders Funds | -901 | 4.841 | 10.511 | 7.915 | 8.178 | 15.091 | 16.589 | 10.411 | 8.725 | 7.751 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 14.671 | 11.943 | 15.625 | 7.499 | 5.904 | 13.279 | 14.151 | 5.284 | 4.716 | 8.214 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "162 - 162" | |||||||||
| CAEN Financial Year |
162
|
|||||||||
Comments - Semliv Genetic International Srl